Tradestie Institutional Equity Comparison Engine

CDT vs ABVEW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVEW Overall Edge

ABVEW Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Above Food Ingredients Inc. Warrants (ABVEW) driven by superior Momentum & Technical, Options & Structure while CDT counters with relative strength in Growth & Margin. Fundamentally, CDT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABVEW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ABVEW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CDT N/M vs ABVEW N/M Fwd P/E
Growth & Margin Winner CDT
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner ABVEW
1Y -86.8% vs -64.7% ยท 52W Pos 2% vs 0%
Options & Structure Winner ABVEW
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
CDT NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap $507,528
1M Return +76.79%
1Y Return -86.78%
Forward P/E N/M
Unified AI Score
31.6 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 54.0
ABVEW NASDAQ
Above Food Ingredients Inc. Warrants
Institutional Equity
$0.02
-86.37% 1D
Market Cap N/A
1M Return -87.14%
1Y Return -64.71%
Forward P/E N/M
Unified AI Score
37.2 / 100 SELL
Tech 25.0 Fund 42.0 Flow 50.0 Mom 53.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CDT -86.78% ABVEW -64.71% Spread: +48.39 pp (CDT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CDT TTM Op. Margin: 0.0% ABVEW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CDT vs ABVEW. Trailing 12-month operating profitability (CDT 0.0% vs ABVEW N/A) and valuation multiples (CDT N/M vs ABVEW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CDT (6) vs ABVEW (2)
Institutional Metric CDT ABVEW Criterion Row Winner
Market Capitalization Scale $507,528 N/A Larger Scale CDT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth CDT
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin CDT
Net Profit Margin Profitability 0.0% N/A Higher Margin CDT
Return on Equity (ROE) Capital Efficiency -69.7% N/A Higher ROE CDT
52-Week Range Position Momentum 2% ($0โ€“$11) 0% ($0โ€“$2) Stronger Trend CDT
Beta / 30D Volatility Risk Regime -17.75ฮฒ ยท 10175% Vol 4.07ฮฒ ยท 408% Vol Lower Realized Risk ABVEW
Unified Institutional Score Composite Signal 31.6 / 100 (SELL) 37.2 / 100 (SELL) Higher Composite ABVEW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CDT vs ABVEW Buy Guide
CDT BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABVEW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABVEW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CDT nor ABVEW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.